Coloboma, congenital heart disease, ichthyosiform dermatosis, mental retardation, and ear anomalies (CHIME) syndrome is a very rare autosomal recessive neuroectodermal disorder that was initially described by Zunich and Kaye in 1983. 1 This disease entity is related to pathogenic variants in the gene coding for the phosphatidylinositol glycan anchor biosynthesis class L (PIGL) protein (OMIM #280000), an enzyme located at the membrane of the endoplasmic reticulum. PIGL catalyzes the second step in glycosylphosphatidylinositol (GPI) biosynthesis, that is, the de-N-acetylation of N-acetylglucosaminyl-phosphatidylinositol. 2 GPI has a critical role in the anchoring of many membrane proteins, some of which are involved in neurogenesis. 3 To date, only eight cases of CHIME syndrome in people with confirmed PIGL variants have been reported. [4][5][6] Given the rarity of this syndrome, data on its clinical features and clinical spectrum are scarce. All six of the cases reported by Ng et al. 4 carried a compound heterozygous variant c.500T>C, p.(Leu167Pro). A second pathogenic variant was identified in 5 of the 6 patients. 4 In the seventh case of PIGL-related CHIME syndrome (reported by Knight Johnson et al. 5 ), the c.500T>C, p.(Leu167Pro) variant was again detected on the first allele but the second allele carried an intragenic deletion of PIGL's exons 4-6. In the eighth case (reported